[Local intravenous fibrinolysis in deep cerebral vein thrombosis]. 2007

R Huber, and H-J Gdynia, and P Kühnlein, and B Schmitz
Neurologische Klinik der Universität Ulm im Rehabilitationskrankenhaus Ulm, Oberer Eselsberg 45, Ulm, Germany.

Acute cerebral vein and dural sinus thrombosis are usually treated with unfractionated intravenous heparin. Progression of symptoms after appropriate heparin dosage appears to be a rare event. In the literature only single case reports or small case series dealing with local intravenous fibrinolysis are available. Here we describe a 44-year-old woman with progressive thrombosis of the sinus rectus and right sinus transversus upon an appropriate dosage of heparin who was successfully treated with urokinase 12 h after symptom onset. This case demonstrates that local thrombolysis should be discussed in patients with progression of the clinical or radiological picture under sufficient heparin therapy.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D002550 Cerebral Veins Veins draining the cerebrum. Basal Vein,Pial Vein,Sylvian Vein,Thalamostriate Vein,Vein of Galen,Terminal Vein,Basal Veins,Cerebral Vein,Galen Vein,Pial Veins,Terminal Veins,Thalamostriate Veins,Vein, Basal,Vein, Cerebral,Vein, Pial,Vein, Sylvian,Vein, Terminal,Vein, Thalamostriate,Veins, Basal,Veins, Cerebral,Veins, Pial,Veins, Terminal,Veins, Thalamostriate
D005260 Female Females
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D020767 Intracranial Thrombosis Formation or presence of a blood clot (THROMBUS) in a blood vessel within the SKULL. Intracranial thrombosis can lead to thrombotic occlusions and BRAIN INFARCTION. The majority of the thrombotic occlusions are associated with ATHEROSCLEROSIS. Brain Thrombosis,Cerebral Thrombosis,Thrombosis, Brain,Thrombosis, Intracranial,Brain Thrombus,Cerebral Thrombus,Thrombus, Intracranial,Brain Thromboses,Cerebral Thromboses,Intracranial Thromboses,Intracranial Thrombus,Thromboses, Brain,Thromboses, Cerebral,Thromboses, Intracranial,Thrombosis, Cerebral,Thrombus, Brain,Thrombus, Cerebral

Related Publications

R Huber, and H-J Gdynia, and P Kühnlein, and B Schmitz
May 1969, Lancet (London, England),
R Huber, and H-J Gdynia, and P Kühnlein, and B Schmitz
March 1974, Lancet (London, England),
R Huber, and H-J Gdynia, and P Kühnlein, and B Schmitz
February 1994, Pediatric neurology,
R Huber, and H-J Gdynia, and P Kühnlein, and B Schmitz
September 1976, The British journal of surgery,
R Huber, and H-J Gdynia, and P Kühnlein, and B Schmitz
November 1973, Lancet (London, England),
R Huber, and H-J Gdynia, and P Kühnlein, and B Schmitz
February 1994, Deutsche medizinische Wochenschrift (1946),
R Huber, and H-J Gdynia, and P Kühnlein, and B Schmitz
January 1980, The British journal of surgery,
R Huber, and H-J Gdynia, and P Kühnlein, and B Schmitz
January 1991, VASA. Supplementum,
R Huber, and H-J Gdynia, and P Kühnlein, and B Schmitz
September 1999, Revue neurologique,
R Huber, and H-J Gdynia, and P Kühnlein, and B Schmitz
April 1972, The British journal of surgery,
Copied contents to your clipboard!